J P Mohr Selected Research

Heparin (Liquaemin)

8/2002

[Prevention of recurrent ischemic stroke: recent clinical trial results].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J P Mohr Research Topics

Disease

27	Stroke (Strokes) 01/2018 - 01/2002
18	Ischemic Stroke 10/2016 - 03/2000
11	Heart Failure 01/2018 - 01/2008
5	Hemorrhage 09/2015 - 11/2001
4	Arteriovenous Malformations (Arteriovenous Malformation) 10/2017 - 02/2000
4	Patent Foramen Ovale 07/2009 - 06/2002
3	Cerebral Hemorrhage 01/2016 - 01/2013
3	Embolic Stroke 09/2004 - 08/2002
2	Transient Ischemic Attack 01/2016 - 03/2003
2	Atrial Fibrillation 03/2013 - 08/2002
2	Carotid Stenosis (Carotid Artery Stenosis) 07/2010 - 01/2000
2	Aphasia (Dysphasia) 03/2003 - 01/2002
2	Paresis (Hemiparesis) 01/2002 - 01/2000
1	Thromboembolism 01/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2016
1	Hypertension (High Blood Pressure) 09/2015
1	Systolic Heart Failure 01/2014
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 05/2012
1	Carotid Artery Diseases 02/2012
1	Myocardial Infarction 07/2010
1	Left Ventricular Dysfunction 01/2008
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 03/2006
1	Aneurysm (Aneurysms) 06/2002
1	Brain Ischemia (Cerebral Ischemia) 01/2002
1	Perceptual Disorders (Hemispatial Neglect) 01/2002
1	Embolism (Embolus) 11/2001
1	Pathologic Constriction (Stenosis) 01/2000
1	Horner Syndrome (Horner's Syndrome) 01/2000
1	Intracranial Arteriovenous Malformations (Cerebral Arteriovenous Malformation) 01/2000
1	Pain (Aches) 01/2000

Drug/Important Bio-Agent (IBA)

21	Warfarin (Coumadin)FDA LinkGeneric 01/2018 - 11/2001
21	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2017 - 11/2001
4	AnticoagulantsIBA 01/2018 - 01/2003
4	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2018 - 11/2001
3	Antiphospholipid AntibodiesIBA 07/2009 - 08/2002
2	Anticardiolipin AntibodiesIBA 07/2009 - 02/2004
2	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 07/2009 - 02/2004
2	Tissue Plasminogen Activator (Alteplase)FDA Link 02/2006 - 01/2002
2	Midazolam (Versed)FDA LinkGeneric 03/2003 - 01/2002
1	Angiotensin Receptor AntagonistsIBA 01/2017
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2017
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2017
1	Hemoglobins (Hemoglobin)IBA 01/2016
1	Urea (Carbamide)FDA LinkGeneric 01/2016
1	NitrogenIBA 01/2016
1	Brain Natriuretic Peptide (Natrecor)FDA Link 03/2013
1	pro-brain natriuretic peptide (1-76)IBA 03/2013
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2008
1	Carbon DioxideIBA 03/2006
1	Thrombin FDA Link 09/2004
1	Hemostatics (Antihemorrhagics)IBA 09/2004
1	Prothrombin (Factor II)IBA 09/2004
1	AntibodiesIBA 02/2004
1	Pharmaceutical PreparationsIBA 03/2003
1	Heparinoids (Heparinoid)IBA 08/2002
1	Heparin (Liquaemin)FDA LinkGeneric 08/2002
1	gamma-Aminobutyric Acid (GABA)IBA 01/2002
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2002
1	A-factor (Streptomyces)IBA 01/2000
1	Retinaldehyde (Retinal)IBA 01/2000
1	Anesthetics (Anesthetic Agents)IBA 01/2000

Therapy/Procedure

15	Therapeutics 10/2017 - 01/2002
3	Endarterectomy (Thromboendarterectomy) 12/2012 - 01/2000
2	Carotid Endarterectomy 12/2012 - 07/2010
2	Thrombolytic Therapy 06/2002 - 03/2000
1	Thrombectomy 05/2003
1	Treatment Delay 06/2002
1	Catheters 01/2002
1	Radiotherapy 02/2000
1	Injections 01/2000
1	Therapeutic Embolization 01/2000